Some symptoms may be mild and improve with dose adjustment, hydration, meal timing, smaller meals, protein planning, or nutrition changes
Lisa DiFrancesco is a female board-certified plastic surgeon based in Atlanta, GA
Only when Eli Lilly began testing dual GLP-1/GIP agonists did the picture change dramatically
For most, the great decision theyre going to make comes down to what suits their health requirements and goals
Individual experiences and weight loss results vary, and your provider will adjust your treatment plan based on your response
Metabolic impact : The mechanisms by which these medications improve insulin secretion, suppress glucagon, delay gastric emptying, and reduce appetite are all dose-related